Claudie Charbonneau

3.1k citations
70 papers · 2.2k indexed · 2 hit papers · h-index 19
Topics
Renal cell carcinoma treatment (20 papers)Economic and Financial Impacts of Cancer (19 papers)Antifungal resistance and susceptibility (18 papers)
Journals
Journal of Clinical OncologySHILAP Revista de lepidopterologíaCancer

In The Last Decade

Claudie Charbonneau

65 papers receiving 2.2k citations

Hit Papers

Epidemiologic and socioeconomic burden of metastatic rena...200820262014202020082019250500750

Peers

Claudie Charbonneau
Comparison fields: 5 of 120
  • Pulmonary and Respiratory Medicine 962
  • Molecular Biology 732
  • Oncology 456
  • Epidemiology 390
  • Applied Microbiology and Biotechnology 367
Replace Pui San Tan with:
Pui San Tan United Kingdom
Styliani Karanika United States
Joan Korth‐Bradley United States
Gary Dukart United States
Antonis Valachis Sweden
Nikolaos Andreatos United States
Laura H. Rosenberger United States
Liat Vidal Israel
Gottfried J. Locker Austria
Helmut Ostermann Germany
Claudie Charbonneau relative to Pui San Tan United Kingdom Pui San Tan's profile →
Citations per field
00.5×7.4×
Pui San Tan · 1×
Citations per year

Countries citing papers authored by Claudie Charbonneau

Since Specialization
Citations

This map shows the geographic impact of Claudie Charbonneau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudie Charbonneau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudie Charbonneau more than expected).

Fields of papers citing papers by Claudie Charbonneau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudie Charbonneau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudie Charbonneau. The network helps show where Claudie Charbonneau may publish in the future.

Co-authorship network of co-authors of Claudie Charbonneau

This figure shows the co-authorship network connecting the top 25 collaborators of Claudie Charbonneau. A scholar is included among the top collaborators of Claudie Charbonneau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudie Charbonneau. Claudie Charbonneau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1
Ceftaroline Fosamil for the Empiric Treatment of Hospitalized Adults with cSSTI: An Economic Analysis from the Perspective of the Spanish National Health System
3
2 0
3 11
4 3
5 16
6 2
7 0
8 3
9 2
10
Economic analysis of empiric versus diagnostic-driven strategies for immunocompromised patients with suspected fungal infections in the People's Republic of China
3
11 3
12 8
13 10
14 13
15 16
16 5
17 46
18 3
19
Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): A literature reviewbreakdown →
774
20 24

About Claudie Charbonneau

Claudie Charbonneau is a scholar working on Applied Microbiology and Biotechnology, Infectious Diseases and Molecular Medicine, having authored 70 papers that have together received 2.2k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (20 papers), Economic and Financial Impacts of Cancer (19 papers) and Antifungal resistance and susceptibility (18 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (367 citations), Pulmonary and Respiratory Medicine (962 citations) and Molecular Medicine (137 citations). Claudie Charbonneau has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include Jim Z. Li, Jeffrey D. Miller, Mason W. Russell, Kiran Gupta, Jennifer Stephens, Dilip Nathwani, Della Varghese, Stéphan Martin, Wajeeha Ansari and Robert J. Motzer. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026